2024-08-17 d. 國際2F 討論室B
時間主題
15:30 ~ 15:50
海報瀏覽時間
座長: 張兆祥,
王弘仁
15:50 ~ 15:54
MP03-01: Real-world application of Darolutamide in non-metastatic castration-resistant prostate cancer in taiwan: A single-center experience
講者: 莊惠娟 座長: 張兆祥,
王弘仁
15:54 ~ 15:58
MP03-02: The impact of BMI on outcome of robotic-assisted radical prostatectomy: A single-center retrospective study
講者: 陳正宇 座長: 張兆祥,
王弘仁
15:58 ~ 16:02
MP03-03: Clinical effect of Denosumab in metastatic castration resistant prostate cancer – retrospective observational study
講者: 吳敏瑞 座長: 張兆祥,
王弘仁
16:02 ~ 16:06
MP03-04: Long non-coding RNA OIP5-AS1 modulates upper tract urothelial carcinoma cell migration and invasion through regulating miR-340-5p/versican axis
講者: 吳奕儒 座長: 張兆祥,
王弘仁
16:06 ~ 16:10
MP03-05: Development and validation of early recurrence predicting model in patients with localized upper tract urothelial carcinoma treated by radical nephroureterectomy
講者: 張嘉論 座長: 張兆祥,
王弘仁
16:10 ~ 16:14
MP03-06: Analysis for bladder recurrence of upper tract urothelial carcinoma following radical nephroureterectomy with transurethral bladder cuff excision and pluck method
講者: 林奇柏 座長: 張兆祥,
王弘仁
16:14 ~ 16:18
MP03-07: Survival outcomes and clinical characteristics of variant histology in upper tract urothelial carcinoma
講者: 吳英龍 座長: 張兆祥,
王弘仁
16:18 ~ 16:22
MP03-08: Is neoadjuvant immune checkpoint inhibitors-base treatment beneficial to managements of locally advanced upper tract urothelial carcinoma (UTUC)?
講者: 李彥霓 座長: 張兆祥,
王弘仁
16:22 ~ 16:26
MP03-09: Different treatment patterns and survival outcomes based on Cisplatin eligibility in patients with advanced urothelial carcinoma receiving first-line systemic therapy
講者: 曾聖修 座長: 張兆祥,
王弘仁
16:26 ~ 16:30
MP03-10: Adrenal vein sampling and its correlation with image and surgical outcome - a single-center cases series and literature review
講者: 許淳淵 座長: 張兆祥,
王弘仁